The Microdose asked OpenAI's chatbot for its insights on psychedelic therapy.
The Microdose is an independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics. Each week they ask an expert five questions about the evolving field. This week they asked ChatGPT five questions "about psychedelics to see what kind of information it might provide to would-be searchers. To probe its strengths and weaknesses, we asked ChatGPT a variety of questions. In general, the chatbot provided cogent, comprehensive summaries of issues in psychedelics. In most of its answers, ChatGPT also included caveats about safety and legality and encouraged consulting medical professionals before using psychedelics."
"...But the chatbot’s most interesting replies were its insights into its own potential role in the future of psychedelics, and its replies to what we might think of as uniquely human experiences, including mysticism and poetry." - jane c. hu
Article: Can AIs Provide Psychedelic Therapy? 5 Questions for Chatbot ChatGPT
Related Article: MINDCURE Announces Partnership with Speak Ai to Enhance iSTRYM, the Company's Psychedelic Digital Therapeutics Technology Platform